Doses of folic acid greater than 0.1 mg per day may result in hematologic remission in patients with vitamin B12 deficiency
Since peptides like 5-Amino-1MQ naturally occur in the body in various forms, this therapy is designed to align closely with the bodys biological systems, making it a well-tolerated and promising option for those seeking enhanced metabolic health, longevity, and improved physical resilience
However, the lack of human clinical trials means long-term safety in people remains unknown
Weekly injections in this phase are important for: Keeping B12 stores full Watching how the patient responds and adjusting as needed Starting to move to less frequent injections Maintenance Phase: Monthly Injections After the first two phases, maintenance therapy starts with monthly injections
Once peptides have been received, it is imperative that they are kept cold and away from light
As of writing, 5-amino-1MQ is not approved for human use but is available as a research chemical for laboratory experimentation